The International Society of Refractive Surgery honors Vivior Chairman with Casebeer Award

NewsGuard 100/100 Score

Michael Mrochen, PhD, Chairman of the Board of Directors at Vivior, receives the Casebeer Award from the International Society of Refractive Surgery.

The International Society of Refractive Surgery (ISRS), a partner of the American Academy of Ophthalmology, is the leading worldwide organization for refractive surgeons. Each year, ISRS awards members for their special contributions to the ISRS, as well as their dedication to the field. The Casebeer Award recognizes an individual for his or her outstanding contributions to refractive surgery through nontraditional research and development activities (https://www.isrs.org/about-isrs/awards).

Michael Mrochen is internationally known for his pioneering work on corneal laser surgery, corneal cross linking, ocular biometry and cornea inlays for presbyopia and hyperopia.

Mario Stark, CEO at Vivior, highlights that "we are proud at Vivior that the ISRS recognizes the outstanding work that Michael has done over the decades to advance the treatment options in ophthalmology. It is an honor for us to have him as Chairman".

Mr. Arthur Cummings, Chairman of the Vivior Medical Advisory Board, adds that "Michael is an innovator par excellence, bringing scientific advancements to the surgeon to help us all offer the best treatment to our patients".

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
What does the future hold for obesity medication development?